Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Ottignies

8 clinical trials in Ottignies, Belgium across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ottignies at a glance
8
clinical trials
  • Paediatric trials0
  • Research sites2
Type of trial
Recruitment status
Quick filters

8 trials in Ottignies

Open in trial search
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Universitaire De Liege
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Medisch Centrum Utrecht
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Ciclosporin A
  • Sponsor:Labo'Life Belgium

Loss of consciousness

Not yet recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Mannitol
  • Sponsor:Universite De Liege

Brain injury+1

Not yet recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ketamine
  • Sponsor:Centre Hospitalier Universitaire De Liege
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Soticlestat
  • Sponsor:Takeda Development Center Americas Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Unicancer

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Ottignies

What the registry says about research in the country

01 Ottignies
Neurology and Consciousness Disorders
Clinical research in Ottignies includes studies focused on nervous system diseases and the recovery of patients with disorders of consciousness after severe brain injury or coma. These trials are exploring whether targeted therapies can improve wakefulness, responsiveness, and overall neurological recovery. Evaluation of ketamine for post-comatose patients with impaired consciousness Assessment of apomorphine hydrochloride for severe brain injury and consciousness recovery Study of zolpidem responses in patients with disorders of consciousness Research into the mechanisms behind paradoxical neurological responses Together, these trials aim to improve treatment options and deepen understanding of how the brain may respond to therapy in complex neurological conditions.
Respiratory Infections and Critical Care
Another active area of research covers respiratory tract diseases, especially severe community-acquired pneumonia and broader respiratory tract infection care in hospitalized patients. The goal is to identify better ways to support recovery and reduce serious outcomes in people admitted with acute infections. Testing supportive interventions for hospitalized patients with acute respiratory tract infection Evaluating treatment options for severe community-acquired pneumonia Measuring effects on survival and recovery over time This line of research is particularly relevant for intensive care settings, where timely and effective treatment can strongly influence patient outcomes.
Oncology and Breast Cancer
In the field of neoplasms, trials are studying advanced breast cancer with specific genetic features, including ER-positive and HER2-negative disease. Research is centered on whether new treatment combinations can improve disease control in patients with hard-to-treat cancers. Testing a combination approach for selected metastatic breast cancer patients Focusing on tumors with BRCA and HRR alterations Assessing benefits in patients with advanced hormone-receptor-positive disease These studies are designed to evaluate treatment effectiveness and offer more personalized options for people with genetically defined cancer subtypes.
Epilepsy and Rare Neurological Syndromes
Research in nervous system diseases also includes long-term treatment studies for rare epileptic disorders such as Dravet syndrome and Lennox-Gastaut syndrome. The emphasis is on improving seizure control while keeping therapy safe and tolerable over time. Long-term safety evaluation of soticlestat as add-on therapy Support for patients already receiving standard epilepsy care Focus on chronic management of Dravet syndrome and Lennox-Gastaut syndrome This research is important for families and clinicians seeking better options for rare and severe seizure disorders.
Women’s Health and Viral Infections
Within female urogenital diseases and pregnancy-related conditions, clinical trials are examining human papillomavirus infection and strategies to help clear persistent genital HPV. The main purpose is to test whether new approaches can improve infection outcomes and reduce long-term risk. Comparing a candidate intervention with placebo for genital HPV clearance Targeting high-risk oncogenic HPV infections Supporting prevention efforts in women’s health This area links infection control with cancer prevention, making it a meaningful focus in preventive medicine.
Vision Research and Physiological Responses
A smaller but distinctive research stream examines physiological processes in people with acquired partial or total vision impairments and in neurotypical volunteers. These studies aim to better understand unusual responses to treatment and how such responses may inform personalized care. Studying temporary visual improvement in patients with vision impairments Comparing responses in volunteers and patient groups Exploring how unusual drug responses may reveal biological mechanisms The findings may help clarify why some individuals respond differently to the same treatment and support more tailored clinical decisions.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.